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ABSTRACT The human roseoloviruses human herpesvirus 6A (HHV-6A), HHV-6B,
and HHV-7 comprise the Roseolovirus genus of the human Betaherpesvirinae subfam-
ily. Infections with these viruses have been implicated in many diseases; however, it
has been challenging to establish infections with roseoloviruses as direct drivers of
pathology, because they are nearly ubiquitous and display species-speciﬁc tropism.
Furthermore, controlled study of infection has been hampered by the lack of experi-
mental models, and until now, a mouse roseolovirus has not been identiﬁed. Herein
we describe a virus that causes severe thymic necrosis in neonatal mice, character-
ized by a loss of CD4 T cells. These phenotypes resemble those caused by the pre-
viously described mouse thymic virus (MTV), a putative herpesvirus that has not
been molecularly characterized. By next-generation sequencing of infected tissue ho-
mogenates, we assembled a contiguous 174-kb genome sequence containing 128
unique predicted open reading frames (ORFs), many of which were most closely re-
lated to herpesvirus genes. Moreover, the structure of the virus genome and phylo-
genetic analysis of multiple genes strongly suggested that this virus is a betaherpes-
virus more closely related to the roseoloviruses, HHV-6A, HHV-6B, and HHV-7, than
to another murine betaherpesvirus, mouse cytomegalovirus (MCMV). As such, we
have named this virus murine roseolovirus (MRV) because these data strongly sug-
gest that MRV is a mouse homolog of HHV-6A, HHV-6B, and HHV-7.
IMPORTANCE Herein we describe the complete genome sequence of a novel mu-
rine herpesvirus. By sequence and phylogenetic analyses, we show that it is a beta-
herpesvirus most closely related to the roseoloviruses, human herpesviruses 6A, 6B,
and 7. These data combined with physiological similarities with human roseolovi-
ruses collectively suggest that this virus is a murine roseolovirus (MRV), the ﬁrst de-
ﬁnitively described rodent roseolovirus, to our knowledge. Many biological and clini-
cal ramiﬁcations of roseolovirus infection in humans have been hypothesized, but
studies showing deﬁnitive causative relationships between infection and disease sus-
ceptibility are lacking. Here we show that MRV infects the thymus and causes T-cell
depletion, suggesting that other roseoloviruses may have similar properties.
KEYWORDS herpesviruses, roseolovirus
The study of herpesviruses has been fruitful, not only revealing mechanisms thatdrive disease but also providing insight into diverse processes, including oncogen-
esis and immune regulation (1). The Herpesviridae family includes several highly prevalent
human pathogens (1–3). While they are related, these viruses have diverse genomes,
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particularly in their regions ﬂanking conserved central core regions, and display distinct
pathophysiologies. Many human herpesviruses belonging to the Alphaherpesvirinae (her-
pes simplex virus [HSV]), Betaherpesvirinae (human cytomegalovirus [HCMV]), and Gamma-
herpesvirinae (Epstein-Barr virus [EBV], Kaposi’s sarcoma-associated virus [KSHV]) subfamilies
have been scrupulously characterized. However, human herpesvirus 6A (HHV-6A), HHV-6B,
and HHV-7 (HHV-6A/6B/7) are highly related members of the less-well-characterized Rose-
olovirus genus of the human Betaherpesvirinae subfamily. HHV-6B is among the most
prevalent human herpesviruses, but little is known about its pathogenesis, disease se-
quelae, or the host immune response (4).
Ninety-ﬁve percent of humans are seropositive for either HHV-6A or HHV-6B by 2
years of age (5), and roseoloviruses are associated with many conditions, including
encephalitis (6, 7), seizures (8, 9), dermatologic disease (10, 11), and multiple sclerosis
(12–15). Epidemiological studies in humans linking HHV-6A/6B/7 to disease are limited
because of the high prevalence of infection, leaving very few uninfected individuals for
comparison. Furthermore, although many studies have identiﬁed correlations between
diseases and HHV-6A/6B viremia, causality cannot be deﬁnitively proven, as the alter-
native interpretation that viremia and disease are caused by a common trigger remains.
Thus, better experimental systems that allow for controlled study of roseolovirus
biology may yield improved insight into a number of human diseases.
Tractable tools that allow for the study of herpesviruses in vitro and in animal
models have been essential to understanding their mechanisms of pathogenesis. Many
herpesviruses display species-speciﬁc tropism, which prevents direct study of important
human pathogens, such as HCMV, EBV, KSHV, HHV-6A, HHV-6B, and HHV-7. However,
in the cases of HCMV and EBV/KSHV, there exist the related rodent viruses murine
cytomegalovirus (MCMV) and murine gammaherpesvirus 68 (HV68), respectively,
which have been useful in broadening insight into the diseases caused by these viruses.
MCMV and HV68 are clearly related to their human counterparts by sequence homol-
ogy. Moreover, they share common mechanisms of pathogenesis and their homolo-
gous genes (3, 16, 17) exhibit similar functions. For instance, MCMV infection recapit-
ulates most aspects of HCMV disease, with the exception of congenital infection due to
the lack of placental infection (18). Similarly, a better understanding of HHV-6A/6B/7
pathophysiology would be aided by mouse homologs, but none have been previously
identiﬁed.
Here we describe genome sequencing of a murine herpesvirus with properties that
resemble those of murine thymic virus (MTV, murid herpesvirus 3), a previously
identiﬁed virus (19). Genome analysis showed that it is a mouse betaherpesvirus most
closely related to human herpesviruses 6A, 6B, and 7, indicating that the virus is a
murine roseolovirus. Despite similarities between this roseolovirus and MTV, we were
unable to verify that our virus stocks and MTV were derived from a common source.
Furthermore, the genome of MTV was never published, preventing genetic compari-
sons. As such, we have named this agent murine roseolovirus (MRV).
RESULTS
MRV is a murine herpesvirus related to human roseoloviruses. Infection with
our virus stocks showed thymic necrosis and depletion of T cells in the thymus and
spleen in BALB/c neonates (Fig. 1A and B). Depletion was evident in the CD4 single
positive (CD4 SP) subsets in the thymus, as previously reported for MTV (20). We
observed reductions in double positive (CD4 CD8, DP) thymocytes, and both major
T-cell subsets (CD4 and CD8) in the spleen. Transmission electron micrographic
(TEM) images of cells from infected thymi revealed virus-like particles in most cells (Fig.
1C). Similar to the ﬁndings in prior publications on MTV (19), these hyperdense virions
measured approximately 150 nm and were often found in concentric circles surround-
ing double-membrane cytoplasmic vesicles. In contrast, images obtained from age-
matched control mice had no visible virus-like particles. While these phenotypes were
also observed after MTV infection, the absence of freely available sequence information
Patel et al. Journal of Virology
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FIG 1 MRV infection depletes thymic and peripheral CD4 cells, and virus particles are observable in
thymi of infected mice. (A and B) Flow cytometry on thymus and spleen 10 days postinfection with MRV.
Thymic cells were gated on live lymphocytes, and spleen cells were gated on live, CD3 lymphocytes,
with dot plots (A) and absolute quantiﬁcation (B) with each point representing a single mouse. Open
circles represent uninfected control mice; ﬁlled circles represent infected mice. Results for thymocyte
subsets, CD4 SP (single positive CD4), DP (CD4 CD8), CD8 SP (single positive CD8), DN (CD4 CD8),
and splenic subsets are shown. (C) Transmission electron microscopy (TEM) of infected and uninfected
thymocytes. Two different cells from an MRV-infected mouse are shown at two different resolutions (with
the higher resolution of a cell with many virions) along with two different thymocytes from an uninfected
control mouse. Data are representative of three or more independent experiments. ****, P  0.0001
(unpaired t test).
Murine Roseolovirus Genome Sequence Journal of Virology
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for MTV and our inability to directly link our virus stock to MTV prevented us from
concluding that this virus and MTV are the same.
We determined the primary genome sequence of this virus to assess its phylogeny.
Since our virus, like MTV, has not been grown in tissue culture and a cloned virus is not
available, DNA was harvested from the thymus of a BALB/c neonate at 7 days postin-
fection. We generated libraries using Paciﬁc Biosciences (PacBio) RS II sequencing and
Illumina MiSeq sequencing in tandem to obtain both long, low-ﬁdelity reads and short,
high-ﬁdelity reads, respectively. After excluding reads that mapped to the reference
mouse genome, we performed assembly using PacBio sequencing data and Illumina
sequencing data separately. We then used the long contigs obtained from PacBio
sequencing data assembly as a scaffold to anchor contigs assembled from high-ﬁdelity
Illumina sequencing data. The analysis resulted in an initial unambiguous single
contiguous 156-kb contig (Fig. 2). We extended the sequence through anchoring of our
known ends and searching through the PacBio and Illumina sequencing for reads and
contigs extending beyond our assembled genome and were able to ultimately extend
the genome to 174 kb, reaching the terminal direct repeats (DRs) on both ends of the
genome. For single-nucleotide differences between the PacBio contig and the Illumina
contig, we adopted the Illumina sequence because of the known propensity for errors
to arise in PacBio data. There were 10 regions that were covered only by PacBio contigs
and one region where Illumina data disagreed with PacBio data. We performed PCR
ampliﬁcation and Sanger sequencing of those regions and used Sanger sequencing
FIG 2 Linearized schematic diagram of MRV genome. The MRV genome is represented as a black line, and predicted ORFs are represented by arrows indicating
the direction of transcription. ORFs predicted to be closely related to HHV-6/7 are green, ORFs related to other known proteins are gray, and ORFs with no
similarity to NCBI nonredundant database proteins are shown in red. For MRV ORFs related to HHV-6/7, the corresponding HHV-6/7 homolog is listed adjacent
to the MRV ORF.
Patel et al. Journal of Virology
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data in the ﬁnal genome. We analyzed the variability of the virus genome by remapping
the high-ﬁdelity Illumina reads onto the consensus reference genome. Although we
suspected that the genome from an infected thymus would contain heterogeneity
because the virus had not been previously cloned, we found that the genome had very
little heterogeneity (Fig. 3), allowing for the establishment of the consensus sequence.
Most differences were located near genome termini, with some positions having a
variant frequency exceeding 0.5, which we attribute to multiple alleles contributing less
than 50% of the reads mapped to those sites. In these cases, we assigned the
nucleotide most frequently found to that site in the consensus sequence which may be
reﬁned once an MRV clone is sequenced.
A total of 128 unique open reading frames (ORFs) were identiﬁed in silico as deﬁned
by the presence of a methionine start codon followed by at least 100 amino acids
before a stop codon. Each translated ORF is listed with its length, genomic coordinates,
and its most closely related protein in Table 1. Protein homologs were identiﬁed by
BLASTP analysis of the deduced polypeptide encoded by each individual ORF against
the nonredundant database of protein sequences curated by the National Center for
Biotechnology Information (NCBI) (Table 1). ORFs predicted in the direct repeat regions
of the genome are numbered based on their 3= positions.
The virus genome resembled a herpesvirus genome in structure. Polypeptide trans-
lations of 97 ORFs are related to known proteins, and 65 are closest in sequence
similarity to deduced HHV-6A, HHV-6B, or HHV-7 proteins, suggesting that they are
homologs of these roseolovirus molecules. Many of the remaining ORFs showed closest
similarity to a different herpesvirus species, but they were also signiﬁcantly similar to
deduced HHV-6A/HHV-6B or HHV-7 proteins. As such, we have noted the correspond-
ing HHV-6A/6B/7 homologs (2) for the ORFs in our virus genome (Fig. 2; Table 1).
The virus genome has orthologs of genes in every category of the core herpesvirus
genes that encode proteins involved in gene regulation, nucleotide metabolism, DNA
replication, and virion assembly and function (Table 1). We have annotated herpesvirus
gene blocks 1 through 7 and the betaherpesvirus-speciﬁc gene block (1). The genome
contains almost all betaherpesvirus signature genes (HHV-6 U27, U29, U31, U34 to U41,
U43, U44, U46, U48 to U50, U53, U56, U57, U64 to U67, U70, U72, U74, U76, U77, U82
homologs) (2). While U48A, U80.5, and U99 homologs are missing in the virus genome,
these data strongly support classiﬁcation of this virus as a betaherpesvirus. Long
stretches of the genome mimic the corresponding regions of the genomes of HHV-
6A/6B/7 with the same gene order. Thus, the genomic architecture of this virus
resembles that of betaherpesviruses.
We also performed phylogenetic analyses comparing the catalytic domain of DNA
polymerase, glycoprotein B, and viral single-stranded DNA (ssDNA) binding proteins.
FIG 3 Linearized schematic of the MRV genome plotted against variant frequency. All Illumina sequenc-
ing data were remapped onto the MRV genome by using LoFreq.
Murine Roseolovirus Genome Sequence Journal of Virology
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TABLE 1 Predicted open reading frames of MRVa
Open reading frame Genomic coordinates Strand Size (aa) Protein function/homolog HHV6/7 homolog
ORF 1 10126–10497  123
ORF 2 10457–10783  108
ORF 3 10809–11294  161
ORF 4 11583–11996  137
ORF 5 14290–14688  132
ORF 6 14347–15570  407
ORF 7 16793–17911  372 Tegument protein
ORF 8 18062–19207  381 Tegument protein
ORF 9 19622–19942  106
ORF 10 20021–20584  187
ORF 11 21389–22138  249
ORF 12 22319–22849  176
ORF 13 23039–23854  271 Cell surface glycoprotein OX2
ORF 14 23969–25414  481 UL23
ORF 15 25492–26586  364 UL24
ORF 16 26664–27935  423 Tegument/transactivator UL24
ORF 17 28006–29124  372 U2
ORF 18 29167–30183  338 Tegument protein U3
ORF 19 30511–32121  536 UL27
ORF 20 32168–33592  474 Ribonucleotide reductase large subunit U28
ORF 21 33842–34810  322 U7
ORF 22 34831–35928  365 U8
ORF 23 36021–36353  110
ORF 24 36521–37840  439 U10
ORF 25 3784541963 - 1372 Virion protein U11
ORF 26 4215943127  322 G-protein coupled receptor U12
ORF 27 43275–45320  681 U14
ORF 28 45755–46117  120 U15
ORF 29 46189–46831  184 Immediate early protein U16/U17
ORF 30 48201–48887  228 Envelope glycoprotein U30
ORF 31 49428–50507  359 U19
ORF 32 50536–51768  410 Glycoprotein U20
ORF 33 51719–53068  449 Membrane protein U21
ORF 34 53110–53676  188
ORF 35 53660–54358  232
ORF 36 54650–54967  105
ORF 37 55209–56096  295 UL43
ORF 38 56173–57054  293 U26
ORF 39 57042–58139  365 DNA polymerase processivity subunit U27
ORF 40 58361–59227  288 Capsid assembly and DNA maturation U29
ORF 41 59229–62015  928 Tegument protein U30
ORF 42 62012–68047  2011 Large tegument protein U31
ORF 43 64024–64416  130
ORF 44 64897–65214  105
ORF 45 68276–69664  462 Capsid protein U33
ORF 46 69547–70116  189
ORF 47 69600–70382  260 Nuclear egress protein U34
ORF 48 70353–72155  600 Packaging protein/DNA packaging protein U36
ORF 49 70400–70717  105 DNA packaging protein U35
ORF 50 72148–72921  257 Nuclear egress lamina protein U37
ORF 51 72922–75939  1005 DNA polymerase catalytic subunit U38
ORF 52 73859–74188  109
ORF 53 75932–78403  823 Envelope glycoprotein B U39
ORF 54 78363–80546  727 DNA packaging terminase subunit 2/transport
protein
U40
ORF 55 80594–83968  1124 Single-stranded DNA binding protein U41
ORF 56 84817–86265  482 Multifunctional expression regulator/transactivator U42
ORF 57 86490–89045  851 Helicase/primase U43
ORF 58 89080–89709  209 Hypothetical protein/tegument protein U44
ORF 59 89712–90647  311 Deoxyuridine triphosphatase U45
ORF 60 90978–91556  192 C-type lectin domain containing
ORF 61 91528–92703  391 Envelope glycoprotein O
ORF 62 92957–95062  701 Envelope glycoprotein H U48
ORF 63 95215–95844  209 Nuclear protein U49
ORF 64 95747–97417  556 DNA packaging tegument protein U50
(Continued on following page)
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Open reading frame Genomic coordinates Strand Size (aa) Protein function/homolog HHV6/7 homolog
ORF 65 97489–98403  304 Envelope protein U51
ORF 66 98405–99181  258 U52
ORF 67 99188–100798  536 Capsid maturation protease U53
ORF 68 99349–99747  132
ORF 69 100835–102154  439 Virion transactivator/tegument U54
ORF 70 102206–103549  447
ORF 71 103610–104761  383 U55
ORF 72 104803–105783  326 Capsid triplex subunit 2 U56
ORF 73 105692–109702  1336 Major capsid protein U57
ORF 74 109733–111970  745 U58
ORF 75 111970–112977  335 U59
ORF 76 112974–113918  314 U60
ORF 77 114322–114927  201 U63
ORF 78 114924–116216  430 DNA packaging tegument protein U64
ORF 79 116170–117141  323 Tegument protein U65
ORF 80 117097–118006  302 Putative terminase U66
ORF 81 118005–119030  341 U67
ORF 82 119033–119386  117 Tegument protein U68
ORF 83 119468–121513  681 Tegument serine/threonine kinase U69
ORF 84 119730–120083  117
ORF 85 121506–122960  484 Alkaline exonuclease U70
ORF 86 123116–124156  346 Glycoprotein U72
ORF 87 124180–126513  777 DNA replication origin-binding helicase U73
ORF 88 126480–128375  631 Helicase/primase subunit U74
ORF 89 128368–129105  245 Tegument protein U75
ORF 90 128417–128797  126
ORF 91 129014–130819  601 Capsid portal protein U76
ORF 92 130773–133250  825 Helicase primase subunit/complex U77
ORF 93 132062–132388  108
ORF 94 133358–134431  357
ORF 95 138660–139325  221 U79
ORF 96 139655–140134  159
ORF 97 139992–140330  112
ORF 98 140327–141082  251 Uracil-DNA glycosylase U81
ORF 99 141140–141883  247 Envelope glycoprotein L U82
ORF 100 141339–141665  108
ORF 101 142255–142971  238 Putative glycoprotein
ORF 102 143081–143875  264 Membrane glycoprotein U85
ORF 103 143954–147379  1141 U86
ORF 104 145035–145559  174 Signiﬁcant relationship to hypothetical protein
ORF 105 146791–147249  152
ORF 106 149423–150217  264
ORF 107 150082–150463  126
ORF 108 149422–152068  881
ORF 109 151419–151838  139
ORF 110 155141–157804  887 U95
ORF 111 159258–160181  307
ORF 112 160282–163002  806
ORF 113 161849–162472  207
ORF 114 163357–163683  108
ORF 115 163506–165038  510
ORF 116 163760–164095  111
ORF 117 164171–164578  135
ORF 118 164716–165624  302
ORF 119 165000–165362  120
ORF 120 165057–167831  924
ORF 121 165091–168465  1124
ORF 122 165688–166167  159
ORF 123 165881–166876  331
ORF 124 166828–168465  545
ORF 125 171226–171546  106
ORF 126 171419–171997  192
ORF 127 172098–173450  450
ORF 128 172347–173414  264
aORFs are listed by genome coordinates, strand, size, and predicted function. The ORF nomenclature is based on the corresponding HHV6/7 homolog by BLASTP analysis.
Murine Roseolovirus Genome Sequence Journal of Virology
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Maximum likelihood analysis of the catalytic subunit of DNA polymerase genes from all
ICTV-annotated betaherpesviruses, NCBI-annotated roseoloviruses, and select mouse
and human herpesviruses places the virus into a distinct cluster with betaherpesviruses,
particularly with HHV-6A/6B/7 (Fig. 4A). This virus is more distantly related to another
murine betaherpesvirus, mouse cytomegalovirus (MCMV). More focused examinations
comparing the catalytic domain of DNA polymerase, glycoprotein B, and viral ssDNA
binding proteins from the virus genome with corresponding proteins of representative
mouse and human herpesviruses from each of the three subfamilies, Alphaherpesvirinae
(HSV, varicella-zoster virus [VZV]), Betaherpesvirinae (MCMV, HCMV, HHV-6A, HHV-6B, HHV-
7), and Gammaherpesvirinae (HV68, EBV, KSHV), conﬁrm this classiﬁcation (Fig. 4B). Col-
FIG 4 MRV is most closely related to human herpesviruses 6A, 6B, and 7. (A) Phylogeny based on amino acid sequences
corresponding to the DNA polymerase catalytic subunit of ICTV-recognized herpesviruses and NCBI-classiﬁed roseoloviruses.
(B) DNA polymerase catalytic subunit, glycoprotein B, and ssDNA binding protein are compared to those of known select
mouse and human herpesviruses. Only bootstrap values above 90 are shown; values above 90 are indicated by a single
asterisk, and values of 100 are indicated by two asterisks. Relative genetic distance scale bars are shown above short lines.
Abbreviations: HHV-6A, human herpesvirus 6A; HHV-6B, human herpesvirus 6B; HHV-7, human herpesvirus 7; MCMV, murine
cytomegalovirus, murid herpesvirus 1; HCMV, human cytomegalovirus, human herpesvirus 5; VZV, varicella-zoster virus, human
herpesvirus 3; HSV-1, herpes simplex virus 1, human herpesvirus 1; HSV-2, herpes simplex virus 2, human herpesvirus 2; EBV,
Epstein-Barr virus, human herpesvirus 4; KSHV, Kaposi’s sarcoma-associated herpesvirus, human herpesvirus 8; HV68, murine
gammaherpesvirus 68, murid herpesvirus 4; AoHV1, aotine herpesvirus 1; CbHV1, cebine herpesvirus 1; CeHV5, cercopithecine
herpesvirus 5; MaHV3, macacine herpesvirus 3; PaHV2, panine herpesvirus 2; HVP2, papiine herpesvirus 2; saimiriine HV4,
saimiriine herpesvirus 4; MHV2, murid herpesvirus 2, rat cytomegalovirus; MHV8, murid herpesvirus 8; EEHV, elephantid
herpesvirus 1; CavHV2, caviid herpesvirus 2; SuHV2, suid herpesvirus 2; TuHV1, tupaiid herpesvirus 1; GgorHV7, Gorilla gorilla
herpesvirus 7; PpanHV7, Pan paniscus herpesvirus 7; PtroHV7, Pan troglodytes herpesvirus 7.
Patel et al. Journal of Virology




ay 4, 2017 by W






lectively, these data indicate that this virus is a murine roseolovirus, and therefore we
named it murine roseolovirus (MRV).
MRV contains novel ORFs, including potential immune evasion molecules.
Closely related herpesviruses often display distinct species tropism; for example, the
related viruses HCMV and MCMV are capable of replicating only in human or mouse
cells, respectively (1, 3). While their genomes are highly related, the terminal ends
display the most variability because they encode proteins that interact speciﬁcally with
molecules in their respective hosts. We conducted a prediction of deduced MRV ORF
protein structure and function by Phyre2 and I-TASSER analysis to supplement the
primary sequence homology-based BLASTP analysis.
Two MRV ORF proteins appear to be related to major histocompatibility complex
(MHC) class I-like proteins. Phyre2 analyses showed that predicted proteins from ORF 32
and ORF 94 likely have immunoglobulin-like folds, and I-TASSER predicted that they
were MHC class I-like proteins. Inasmuch as MHC class I-like molecules have diverse
roles in herpesvirus biology, serving as immunomodulatory proteins in immune eva-
sion, we predict similar functions for the MRV deduced proteins (21, 22).
ORF 60 is predicted to encode a protein that structurally resembles a C-type lectin
protein and has 30% sequence identity to mouse C-type lectin domain family 2,
member e (CLEC2e). Although there is no known function for CLEC2e, the CLEC family
of proteins consists of Ca2-dependent carbohydrate-binding proteins with a broad
array of functions, including modulation of cell adhesion, signaling, and immune
regulation (23, 24). Other related lectin-like molecules are functionally important nat-
ural killer cell receptors which can also recognize lectin-like ligands (25, 26). Thus, ORF
60 may modulate the function of these mammalian receptors or ligands.
Given the phenotype observed during MRV infection, we hypothesized that various
viral proteins may speciﬁcally disrupt T-cell biology. ORF 69 is predicted to encode a
homolog to HHV-6/7 protein U54. In HHV-6B, U54 inhibits expression of interleukin 2
(IL-2), an important growth factor for T-cell homeostasis (27), by preventing the
dephosphorylation of NFAT (nuclear factor of activated T cells), thereby blocking its
downstream transcriptional activation of the IL-2 gene (28). HHV-6A U24 is a protein
that downregulates CD3, which signals downstream of the T-cell receptor (29). The MRV
genome does not appear to have a U24 homolog at the corresponding position.
However, the genomic interval between the U19 homolog and the U26 homolog
contains six predicted ORFs, ﬁve of which encode novel proteins. Some of these ORFs
may contain genes providing a similar function in MRV.
Herpesviruses encode various proteins modulating cell death pathways, including
apoptosis and necroptosis (30–32). HHV-6B expresses U19, a protein known to impair
p53-mediated apoptosis. MRV ORF 31 is predicted to encode a homolog of U19.
Innate immune sensors recognize viral nucleic acids and activate pattern recogni-
tion receptors, leading to transcription of type I interferons (IFNs) which initiate major
pathways for antiviral immunity (33). HHV-6A and HHV-6B both encode proteins that
disrupt type I IFN signaling (34), namely, the IE1 proteins which prevent IRF3 dimeriza-
tion, which is required for initiation of interferon-dependent transcriptional programs.
ORF 29 and ORF 31 encode MRV homologs of roseoloviruses IE1 and IE2, respectively,
suggesting that they may dampen type I IFN signaling in mice.
As we expected from a previously uncharacterized genome, we identiﬁed many
potential ORFs with no sequence similarity to those encoding any published proteins,
such as ORF 120, which is predicted by both Phyre2 (100% conﬁdence) and I-TASSER
(Znorm  4.8) to encode a protein resembling the unstructured alpha-helical structure
of collagen 1 alpha 1. By I-TASSER analysis, ORF 123 is predicted to encode a protein
similar to the head component of the yeast spliceosome with a normalized Z-score of
4.64, and ORF 124 resembles components of secretory IgA with a normalized Z-score
of 4.14. The role of these ORFs in virus pathogenesis remains unclear.
MRV infects various tissues in vivo. We have not been able to grow MRV in vitro,
and an in vitro growth system for the related MTV has not been described. As such,
traditional means of establishing virus burden, such as limiting dilution assays and
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plaque assays, are not possible. However, the MRV genome sequence allowed us to
develop a sensitive quantitative PCR (qPCR) assay to detect genome copies of MRV as
a measure of in vivo viral replication (Fig. 5A). Virus genome copies in the thymus
peaked at 7 days postinfection (Fig. 5B). We assayed various organs known to be
infected by herpesviruses (spleen, liver, kidney, salivary gland) or organs in which
human roseoloviruses are known to be present (central nervous system). During acute
infection, MRV was predominately localized to the thymi of infected mice, with low
levels of virus detectable in other organs (Fig. 5C). We also measured MRV genome
copy numbers in mice 7 weeks postinfection and again observed that MRV had a
predilection for the thymus, albeit at signiﬁcantly lower levels than during acute
infection (Fig. 5D). These virus genome copies could represent latent infection in the
thymus or low-level productive viral replication.
DISCUSSION
We performed ultrastructural microscopy and genome sequencing of MRV, which
collectively indicate that it is a herpesvirus. The genomic architecture of MRV along with
sequence similarity of each predicted ORF and phylogenetic analysis of three predicted
ORFs strongly suggest that MRV is more closely related to the human roseoloviruses
than to MCMV, a murine betaherpesvirus. Taken together, the genomic and sequence
data strongly suggest that MRV belongs to the Roseolovirus genus of the Betaherpes-
virinae subfamily in the family Herpesviridae.
MRV is likely related to the previously described MTV, a naturally occurring mouse
herpesvirus (3, 35). MTV was originally identiﬁed by assaying tissue homogenates for
viruses that drive mammary tumorigenesis (19). Blind passage of pooled organs from
adult mice into neonatal mice by intraperitoneal injection reproducibly led to thymic
“necrosis” in infected mice. Subsequent reports indicate that MTV infection of neonates
leads to depletion of CD4 T cells in the thymus of infected animals, whereas adult
FIG 5 MRV preferentially replicates in the thymus. (A) Standard curve of MRV genome copy numbers. The
threshold cycle is plotted as a function of the absolute quantity of a plasmid containing the MRV
genomic target. (B) Time course examining MRV genome copy numbers in thymi of neonatally infected
BALB/c mice as a ratio to mouse actin genome copy numbers. (C and D) MRV genome copy numbers
expressed as a ratio to mouse actin genome copy numbers at 1 week postinfection (C) and 7 weeks
postinfection (D). Data are representative of three or more experiments. Each point represents a single
mouse.
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infections appear to be subclinical, with elevation of anti-MTV antibody titers but no
overt thymic pathology (20, 36, 37). Neonatal depletion of CD4 T cells is transient, as
by 6 weeks postinfection, mice appear to have recovered a normal complement of
CD4 T cells in the spleen and thymus (38). Electron microscopy studies suggest that
MTV has the morphological properties of a herpesvirus (19, 39). Similar to MCMV, MTV
is shed through the salivary glands and can be horizontally transmitted (40, 41), but
MTV is serologically distinct from MCMV (35). MTV has been mentioned to have a DNA
polymerase sequence that is related to herpesviruses, but the sequence has not been
reported (42). While MTV appears to be a herpesvirus, deﬁnitive assessment is not yet
available, and detailed analysis, including that of its genome, is notably absent from the
literature. While we have documented that MRV has many properties similar to those
of MTV, the absence of these data and a direct link between our MRV stock and
previous isolates of MTV prevented us from making determinations about the precise
relationship of MTV to MRV and to other mouse and human herpesviruses. Without this
certainty, we named the virus studied here MRV, as suggested by a reviewer of the
manuscript.
Our report also shows the presence of virus genome copies in various organs. Herein
we showed that MRV inoculation in the peritoneum results in MRV expansion in the
thymus, as determined by our genome copy number assay. We found depletion of
thymocyte subsets, suggesting lytic infection of T cells (20). Our study shows that MRV
is also detectable at lower levels in peripheral organs of the mouse after acute infection,
though this could be related to infected T-cell spread to these organs or viremia rather
than direct infection of these organs.
In addition to the genome sequence similarities, there are other physiological and
functional correlates between MRV and HHV-6. T-cell tropism has been described for
HHV-6, which can replicate and cause lysis of infected T cells in vitro (43, 44). While we
have not studied direct infection of T cells in vitro, our data strongly suggest that MRV
has similar T-cell tropism. Furthermore, infection of humanized mice with HHV-6A
showed severe loss of human CD4 cells in the thymus (45–47), and ex vivo infection
of human lymphoid tissues decreased the CD4 T-cell number (48). The tissue tropism
of human roseoloviruses may be very broad, involving a diverse array of organs and cell
types (1). Taken together, the sequence and functional analyses indicate that MRV is a
murine roseolovirus, related to HHV-6 and HHV-7.
While our data strongly suggest that MRV is a homolog of human roseoloviruses, the
current analyses do not allow ﬁner discrimination to determine if it is more closely
related to HHV-6A, HHV-6B, or HHV-7. The genomes of HHV-6A/6B and HHV-7 can be
distinguished by the presence of several HHV-6-speciﬁc ORFs. Our data indicate that
MRV does not possess homologs of HHV-6 U6, U9, U22, U83, U78, or U94 signature
genes (49). Nonetheless, it is unclear if evolutionarily divergent ORFs have compen-
sated for these ORFs or whether the biology of MRV more closely mimics HHV-7.
Despite the correlates discussed above, there are some notable differences between
MRV and human roseoloviruses, as one might expect from species-speciﬁc herpesvi-
ruses. MRV does possess many signature betaherpesvirus ORFs, but some genes
thought to be roseolovirus speciﬁc are absent from the genome (2). However, these
ﬁndings were not based on a comparison with nonhuman roseolovirus; our MRV
genome sequence should shed additional light on roseolovirus-speciﬁc genes. HHV-6
has been reported to integrate in the telomeres of human chromosomes, while HHV-7
has not been observed to have this property (50–52). HHV-6 integration appears to be
dependent on DR sequences at both ends of its genome, mirroring the hexameric
TTAGGG sequence in human telomeres (53). Our genome does not show correspond-
ing hexameric repeats in the MRV genome, but these data do not preclude the
possibility that MRV could integrate into the mouse genome by unique mechanisms.
Furthermore, there has been no report of large-scale depletion of T cells during
human roseolovirus infection, but to our knowledge, such studies may not have been
systematically conducted, and T-cell depletion may occur at a different time with
respect to the appearance of roseola rash, the usual presenting symptom of primary
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HHV-6 or HHV-7 infection. We hypothesize that similar CD4 cell loss may occur during
primary infection or reactivation of human roseoloviruses and that the thymus may be
an important site for replication, especially in children. Alterations in T-cell number,
diversity, or function may be especially important in the context of childhood vacci-
nations.
Models of HHV-6A and HHV-6B infection have been developed in marmosets and
transgenic mice (46, 47, 54, 55). Additionally, identiﬁcation of naturally occurring
herpesviruses related to human roseoloviruses has been reported by various groups,
notably in pig-tailed macaques (56, 57). Our report extends these studies by identifying
a murine model for roseolovirus infection. The mouse is a particularly useful model
organism for the study of human herpesviruses, and decades of intensive research have
provided countless tools to study host-pathogen interactions.
The pathophysiological etiologies of many of the disorders associated with rose-
olovirus infection are unknown, but our studies suggest that they could also be related
to the loss or altered function of CD4 T cells, in addition to direct infection of speciﬁc
organs. Furthermore, since thymus loss due to MRV occurs primarily in neonates, not
adults, it is possible that there may be age-dependent effects due to HHV-6 or HHV-7
infection. Therefore, we posit that the study of MRV infections will provide insight into
roseolovirus biology that may be more broadly applicable to human infections.
MATERIALS AND METHODS
Virus isolation and infection. Our virus stocks were derived from a vial generously provided by
Robert Livingston at the University of Missouri, Columbia, MO. Given the incomplete passage history and
source of the virus stocks, we were unable to verify that this virus was directly linked to the originally
described MTV (19). Virus stocks were produced by in vivo passaging as previously described (20, 38). A
single virus stock was used for all experiments. Infected mice were intraperitoneally inoculated with 100
l of a 1:10 dilution of thawed virus stock.
Flow cytometry. Single-cell lymphocyte suspensions were prepared from thymi or spleens from
infected animals and processed by manual disruption through a 70-m ﬁlter. A total of 106 to 107 cells
were stained with ﬁxable viability dye, before incubation in 2.4G2 supernatant (anti-FcRII/III). Cells were
stained with surface antibodies (Affymetrix, Santa Clara, CA): anti-CD3 (145-2C11), anti-CD4 (RM4-5), and
anti-CD8 (53-6.7). Samples were run by ﬂow cytometry using a FACSCanto (BD Biosciences, San Jose, CA)
and analyzed using FloJo X (TreeStar, Ashland, OR).
Transmission electron microscopy. For ultrastructural analysis, cells were ﬁxed in 2% paraformal-
dehyde–2.5% glutaraldehyde in 100 mM phosphate buffer, pH 7.2, for 1 h at room temperature. Samples
were washed in sodium cacodylate buffer and postﬁxed in 1% osmium tetroxide (Polysciences, Inc.) for
1 h. Samples were then rinsed extensively in distilled H2O (dH2O) prior to en bloc staining with 1%
aqueous uranyl acetate (Ted Pella, Inc., Redding, CA) for 1 h. Following several rinses in dH2O, samples
were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella, Inc.).
Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems, Inc.,
Bannockburn, IL), stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmis-
sion electron microscope (JEOL USA, Inc., Peabody, MA) equipped with an AMT 8-megapixel digital
camera and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques, Woburn, MA).
MRV genome sequencing. Virus genomic DNA was extracted from the thymus of an infected
neonatal mouse 7 days postinfection. Libraries were generated for sequencing using Paciﬁc Biosciences
RS sequencing (Paciﬁc Biosciences, Menlo Park, CA) and Illumina MiSeq 2X250 sequencing (Illumina, San
Diego, CA), both in accordance with the manufacturer’s protocol. A total of 22,716 reads with a read
length of approximately 113 to 2,201 bp (average, 681 bp) (short reads) and a total of 71,193 reads with
a read length of 114 to 8,506 bp (average, 1,678 bp) (long reads) were obtained by Paciﬁc Bioscience
sequencing at the University of Michigan DNA Sequencing Core. A total of 62,966,095 reads were
obtained by Illumina sequencing at the Genome Technology Access Center in the Department of
Genetics at Washington University School of Medicine. CCS (circular consensus sequence) reads from
Paciﬁc Biosciences RS sequencing were analyzed using VirusHunter (58) to detect virus sequences and
were used for de novo assembly to generate contigs. Illumina MiSeq data were analyzed using the
VirusSeeker program (G. Zhao, unpublished). Contigs generated from both platforms were compared.
Contig sequences generated using Paciﬁc Biosciences RS sequencing data were used as a scaffold to
orient contigs generated using Illumina data. Conﬂicts between the two assemblers were resolved by
targeted PCR and cloning of the amplicon, followed by Sanger sequencing of cloned fragments.
Single-nucleotide polymorphism (SNP) analysis was conducted using LoFreq (MIT, Boston, MA) (59).
Genome analysis. Predicted ORFs were identiﬁed using Snapgene (GSL Biotech LLC, Chicago, IL),
with only ORFs of greater than 100 amino acids in translated length analyzed. Analysis intended to
identify spliced genes was not conducted. Each ORF was queried against the GenBank nonredundant
protein database using the BLASTP algorithm. Novel ORFs were subjected to Phyre2 and I-TASSER
analysis for protein structure modeling (59).
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Phylogenetic analysis. DNA polymerase catalytic subunit (1,005 amino acids [aa]), glycoprotein B
(823 aa), and ssDNA binding protein (1,124 aa) genes were translated from MRV. These sequences were
MUSCLE (60) aligned using SeaView (61). ModelGenerator (59) identiﬁed LG G as the most appropriate
amino acid substitution model. Maximum likelihood methods were implemented in RAxML (62) software.
Phylogenetic trees were visualized using FigTree and stylistically ﬁnished using Adobe Illustrator (Adobe
Systems, San Jose, CA). The viruses compared with MRV and their GenBank accession numbers are as
follows: human herpesvirus 6A, NC_001664.2; human herpesvirus 6B, NC_000898.1; human herpesvirus
7, NC_001716.2; murid herpesvirus 1, NC_004065.1; human herpesvirus 5, FJ616285.1; human herpesvi-
rus 1, X14112.1; human herpesvirus 2, NC_001798.2; human herpesvirus 3, NC_001348.1; human her-
pesvirus 8, NC_009333.1; human herpesvirus 4, NC_007605.1; murid herpesvirus 4, NC_001826; aotine
herpesvirus 1, YP_004940081.1; cebine herpesvirus 1, AEW46233; cercopithecine herpesvirus 5,
YP_004936030.1; macacine herpesvirus 3, AAC05256.1; panine herpesvirus 2, NP_612698.1; papiine
herpesvirus 2, AHM96371.1; saimiriine herpesvirus 4, YP_004940227.1; murid herpesvirus 2, ADB44898.1;
murid herpesvirus 8, YP_007016461.1; elephantid herpesvirus 1, AAG41999.1; caviid herpesvirus 2,
YP_007417829.1; suid herpesvirus 2, ADV78258.1; tupaiid herpesvirus 1, AAD08667.1; Gorilla gorilla
herpesvirus 7, AIN81109.1; Pan paniscus herpesvirus 7, AIN81107.1; and Pan troglodytes herpesvirus 7,
AIN81106.1.
Virus genome copy quantiﬁcation. Genomic DNA was prepared from mouse tissues using a
Puregene extraction kit (Qiagen, Valencia, CA) in accordance with the manufacturer’s recommendations.
Each qPCR utilized a TaqMan Universal PCR master mix, No AmpErase UNG (Life Technologies, Grand
Island, NY), per the manufacturer’s recommendations. MRV-speciﬁc primers amplifying the region from
bp 69992 to bp 70144 are as follows: F, 5= AAACTCCGTTACATGACGGTT 3=; R, 5= GCCATACCGTTTCTTT
GTCTTG 3=, TaqMan probe, 5= TCACCCATACAGACAGATAAACTCTCA 3=. Actin-speciﬁc primers are as
follows: F, 5= AGCTCATTGTAGAAGGTGTGG 3=; R, 5= GGTGGGAATGGGTCAGAAG 3=; TaqMan probe, 5=
TTCAGGGTCAGGATACCTCTCTTGCT 3=. Independent PCRs were run with MRV-speciﬁc primer/probes and
actin-speciﬁc primer/probes. Ampliﬁcation was performed on the Applied Biosystems StepOne Plus qPCR
instrument (Life Technologies, Grand Island, NY). Each reaction was run in triplicate, and the absolute
copy number was quantiﬁed using a standard curve.
Accession number(s). The GenBank accession number for murine roseolovirus (MRV) is KY355735.
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